Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260411008) titled 'Comparison of Antiproteinuric Effect Between High-dose and Low-dose Manidipine in Proteinuric CKD Patients' on April 11.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Navamindradhiraj University
Condition:
Chronic Kidney Disease
Proteinuria
Hypertension
Manidipine
Proteinuria
Chronic Kidney Disease
Calcium Channel Blockers
Antihypertensive Agents
Renal Protection
Manidipine
Proteinuria
Chronic Kidney Disease
Calcium Channel Blockers
Antihypertensive Agents
Renal Protection
Intervention:
Participants receive high-dose manidipine 40 mg once daily for the treatment of proteinuric chron...